Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(99)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(120)
- Bcl-xL(8)
- c-RET(9)
- IAP(27)
- KEAP1-Nrf2(66)
- MDM2(12)
- p53(123)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(8)
- Thymidylate Synthase(10)
- TNF-α(145)
- Other Apoptosis(883)
- APC(6)
- PD-1/PD-L1 interaction(90)
- ASK1(3)
- PAR4(2)
- RIP kinase(52)
- FKBP(20)
- Pyroptosis(31)
- Cat.No. 产品名称 Information
-
GC61532
CCI-007
2-(4-((2-氨基-4-氧代噻唑-5(4H)-亚基)甲基)-2-甲氧基苯氧基)乙酸乙酯
CCI-007 is a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements. -
GC61524
SC-43
An SHP-1 activator
-
GC61492
SW106065
N-(吡啶-3-基)噻吩-2-羧酰胺
SW-106065 is an apoptosis inducer in malignant peripheral nerve sheath tumors (MPNST), which can inhibit ATP consumption of sporadic MPNST and other models of MPNST with an EC50 of 1 ?M. -
GC61466
DMU-212
3,4,5,4'-四甲氧基二苯乙烯
DMU-212 is a methylated derivative of Resveratrol, with antimitotic, anti-proliferative, antioxidant and apoptosis promoting activities, which can induce mitotic arrest via induction of apoptosis and activation of extracellular-signal-regulated kinase1/2 (ERK1/2) protein. -
GC61461
SLF TFA
SLFTFA是FK506结合蛋白(FKBP)的合成配体,对FKBP51的亲和力为3.1μM,对FKBP12的IC50为2.6μM,可用于合成PROTAC分子。
-
GC61437
(E)-Methyl 4-coumarate
4-羟基肉桂酸甲酯; Methyl trans-p-coumarate
A phenol with diverse biological activities -
GC61436
Gallic acid hydrate
没食子酸-水合物; 3,4,5-Trihydroxybenzoic acid hydrate
A phenol with diverse biological activities -
GC61419
Dibenzoylmethane
二苯甲酰甲烷
Dibenzoylmethane是甘草中的次要成分,可激活Nrf2并预防各种癌症和氧化损伤。Dibenzoylmethane是姜黄素的类似物,会引起Keap1解离和Nrf2的核易位。 -
GC61414
ICCB280
(E)-2-(3,4-二羟基苯乙烯基)-3-(2-甲氧基苯基)喹唑啉-4(3H)-酮
ICCB280是一种有效的C/EBPα诱导剂。ICCB280通过激活C/EBPα并影响其下游靶点(例如C/EBPε,G-CSFR和c-Myc),具有抗白血病特性,包括终末分化,增殖停滞和凋亡。 -
GC19607
Raddeanin A
竹节香附素A
Raddeanin A 是海葵 raddeana 的天然三萜皂苷成分,具有抗癌活性。 Raddeanin A 通过 ROS/JNK 和 NF-κB 信号通路对人骨肉瘤发挥抗癌作用。 -
GC19528
1,4-Benzoquinone
对苯醌
A toxic metabolite of benzene -
GC48920
β-Carboline-1-carboxylic Acid
1-Formic Acid-β-carboline
An alkaloid with diverse biological activities -
GC48919
Piliformic Acid
A fungal metabolite
-
GC48907
Metaxalone-d6
AHR438-d6; NSC170959-d6
An internal standard for the quantification of metaxalone -
GC48900
Isocurcumenol
异莪术烯醇
A sesquiterpene with diverse biological activities -
GC48893
Carbazomycin B
A bacterial metabolite with diverse biological activities
-
GC48878
Carbazomycin A
A bacterial metabolite with diverse biological activities
-
GC48850
Carbazomycin C
A bacterial metabolite with diverse biological activities
-
GC48848
Albendazole-d7
阿苯达唑-D7,SKF-62979-d7
An internal standard for the quantification of albendazole -
GC48839
Nifuroxazide-d4
硝呋齐特 d4
An internal standard for the quantification of nifuroxazide -
GC48831
Flutamide-d7
SCH 13521-d7
Flutamide-d7 是氘标记的氟他胺。 -
GC48827
Flufenamic Acid-d4
FFA-d4, Fluphenamic Acid-d4
An internal standard for the quantification of flufenamic acid -
GC48826
Carbazomycin D
A bacterial metabolite with diverse biological activities
-
GC48774
Melicopine
An acridone alkaloid with antimalarial and anticancer activities
-
GC48711
Trypacidin
A fungal metabolite
-
GC48701
QD-394
An inducer of ROS production
-
GC48689
SBP-7455
A dual inhibitor of ULK1 and ULK2
-
GC48676
Monascuspiloin
Monascinol
A fungal metabolite with anticancer activity -
GC48667
Nanangenine C
A drimane sesquiterpene
-
GC48660
Nanangenine F
A drimane sesquiterpene
-
GC48652
Olomoucine II
2-[[[2-[[(1R)-1-(羟基甲基)丙基]氨基]-9-(1-甲基乙基)-9H-嘌呤-6-基]氨基]甲基]苯酚
A CDK inhibitor -
GC48619
Nanangenine B
A drimane sesquiterpene
-
GC48618
Isonanangenine B
SF002-96-1
A drimane sesquiterpene lactone -
GC48609
Nanangenine G
A drimane sesquiterpene
-
GC48580
Penicolinate B
Penicolinate A monomethyl ester
A fungal metabolite with diverse biological activities -
GC48533
Vanoxonin
Antibiotic MG 245CF2A
A bacterial metabolite -
GC48520
Betulonaldehyde
白桦脂醛,半合成
A pentacyclic triterpenoid -
GC48507
Kaempferol 3-O-galactoside
三叶豆苷,Trifolin
A flavonoid with diverse biological activities -
GC48504
Betulinic Aldehyde oxime
桦木醛肟,半合成
A derivative of betulin -
GC48497
Conglobatin C1
A bacterial metabolite
-
GC48493
PCI 45227
依鲁替尼代谢物,PCI-45227
An active metabolite of ibrutinib -
GC48483
Conglobatin B
A bacterial metabolite
-
GC48482
28-Acetylbetulin
28-acetoxy Betulin, 28-O-Acetylbetulin, C-28-Acetylbetulin
A lupane triterpenoid with anti-inflammatory and anticancer activities -
GC48479
Migrastatin
(+)-Migrastatin
A fungal metabolite with antimuscarinic and anticancer activities -
GC48477
Betulinic Acid propargyl ester
An alkyne derivative of betulinic acid
-
GC48470
Ac-DEVD-CHO (trifluoroacetate salt)
N-Ac-Asp-Glu-Val-Asp-CHO
A dual caspase-3/caspase-7 inhibitor -
GC48451
N-(2-Azidoethyl)betulonamide
A pentacyclic triterpenoid intermediate
-
GC48449
28-(Poc-amino)betulin
An alkyne derivative of betulin
-
GC48442
Tryptoquivaline D
Nortryptoquivaline, NSC 292204
A fungal metabolite with anticancer activity -
GC48437
4'-Acetyl Chrysomycin A
A bacterial metabolite with antibacterial and anticancer activities